Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets [Table Text Block]

The value of the Company’s intangible assets as of December 31, 2014, and September 30, 2015 is summarized below (in thousands):

					Human		Anti-ferritin
	Bertilimumab		NanomAbs		Antibodies		Antibody
	iCo		Yissum		Kadouche		MabLife		Total
Balance as of December 31, 2014	$	1,920	$	521	$	521	$	453	$	3,415
Amortization expense		(125)		(35)		(35)		(33)		(228)
Balance, September 30, 2015	$	1,795	$	486	$	486	$	420	$	3,187
Gross asset value	$	2,509	$	694	$	700	$	547	$	4,450
Accumulated amortization		(714)		(208)		(214)		(127)		(1,263)
Balance, September 30, 2015	$	1,795	$	486	$	486	$	419	$	3,187

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Estimated amortization expense for each of the five succeeding years, based upon intangible assets at September 30, 2015 is as follows (in thousands):

Period Ending December 31,	Amount
2015 (3 months)	$	76
2016		305
2017		305
2018		305
2019		305
2020		305
Thereafter		1,586
Total	$	3,187